Dr. Naggie provides strategic vision as well as oversight of the Clinical Research Units (CRUs), Office of Regulatory Affairs and Quality, Institutional Review Board (IRB), and Duke Health Data & Specimen Repository. She also oversees clinical recruitment efforts and guides the development of broad-based research initiatives and other activities to support the School’s growing clinical research enterprise.
Dr. Naggie serves as director of infectious diseases research for the DCRI. She has served as the medical director of the Department of Medicine’s Clinical Research Unit (CRU) since 2017. Dr. Naggie has dedicated her academic career to the care of patients with HIV and viral hepatitis and leads a research program focused on understanding the mechanisms of accelerated liver fibrogenesis in this patient population. She has served as co-chair of the American Association for the Study of Liver Diseases/Infectious Diseases Society of America Hepatitis C Virus (HCV) Guidance Committee and is currently chair of the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee. Dr. Naggie earned her MD from Johns Hopkins School of Medicine and completed her internal medicine training at Duke University, where she also served as a chief resident in Internal Medicine. She completed her Infectious Diseases (ID) fellowship training at Duke, joining the faculty of Duke in the Division of ID in 2009.